Journal of International Obstetrics and Gynecology ›› 2015, Vol. 42 ›› Issue (3): 298-300.

• 综述 • Previous Articles     Next Articles

4G/5G Polymorphism in Promoter Region of PAI-1 Gene and Polycystic Ovary Syndrome

LIU Yuan-wei,DENG Miao,CEN Jia-ping,ZHANG Hong-yan,ZHANG Zhi-fen   

  1. Department of Obstetrics and Gynecology,Hangzhou First People′s Hospital,Hangzhou 310006,China
  • Received:1900-01-01 Revised:1900-01-01 Published:2015-06-15 Online:2015-06-15
  • Contact: ZHANG Zhi-fen

Abstract: Polycystic ovary syndrome(PCOS) is the most common reproductive endocrine disorders,affecting those women of childbearing age,but its pathogenic factors is unknown so far. PCOS has a high degree of familial aggregation,indicating genetic factors play an important role in the pathogenesis. Plasminogen activator inhibitor-1(PAI-1)is the main physiological inhibitor of fibrinolytic system,and a large number of studies have shown that 4G/5G polymorphism in promoter region of PAI-1 gene can effect insulin sensitivity by elevating the level and activity of plasma PAI-1,involved in the formation of insulin resistance (IR). IR is the mainly pathophysiology of PCOS,closely related to obesity and spontaneous abortion of PCOS,prompting that PAI-1 gene 4G/5G polymorphism may have a close relationship with the occurrence and development of PCOS. Therefore,the related research about 4G/5G polymorphism in promoter region of PAI-1 gene and PCOS has become a hot spot in recent years, mainly involved the pathogenesis,obesity,IR,spontaneous abortion and the forward complicated with cardiovascular disease of PCOS,but the conclusion is still controversial.

Key words: Polycystic ovary syndrome, Plasminogen activator inhibitor 1, Insulin resistance, Polymorphism, genetic